It's official. As widely anticipated, the Centers for Medicare & Medicaid Services announced that the nation's physicians would receive a 1.5% increase in payments for services under the Medicare Physician Fee Schedule in calendar year 2004.
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.